Once Was Enough For J&J In Supporting Neutrogena ‘#1 Recommended’ Advertising
J&J Consumer Protests Process, Findings In Second Industry Self-Regulation Review
Executive Summary
J&J Consumer appeals National Advertising Division decision, arguing a “#1 claim” for its Neutrogena personal care line challenged by L’Oréal USA is materially similar to one that NAD attorneys found it supported more than a decade ago.
You may also be interested in...
Dermatologist Survey Lacked Details, Choices To Support Neutrogena ‘#1 Recommended’ Claim
J&J failed to convince BBB National Program’s appeals panel a 2008 NAD decision supporting its “#1 dermatologist recommended” claim for Neutrogena should preclude another review. Panel says market has changed in 12 years since review of Unilever challenge and L’Oreal could make its own challenge.
Survey Says! J&J Prevails Over L’Oreal In NAD ‘#1 Dermatologist Recommended’ Dispute
L’Oreal USA will appeal a National Advertising Division decision advising it to stop claiming that CeraVe is the “#1 dermatologist recommended skincare brand.” J&J challenged the claim, taking issue with the underlying dermatologist survey.
NAD Offers Complex And Fast Tracks: Not All Advertising Claim Reviews Are Alike
NAD will assign three attorneys at the beginning of each Complex Track review instead of one, director Laura Brett said in a recent interview. The industry self-regulation group also recently launched its Fast-Track program for more simple ad claim challenges that rarely have been made.